老虎證券

Bio-Rad Labs misses Q3 estimates for profit, revenue

seekingalpha
2024-11-01
  • Bio-Rad Labs press release (NYSE:BIO): Q3 Non-GAAP EPS of $2.01 misses by $0.87.
  • Revenue of $649.7M (+2.8% Y/Y) misses by $32.45M.
  • Bio-Rad continues to expect its non-GAAP revenue to decline by approximately 2.5% to 4% on a currency-neutral basis.
  • The company estimates a non-GAAP operating margin of between 12.75% to 13.25%, which now also includes the impact of a one-time acquired in-process research and development expense related to an acquisition completed during the third quarter.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10